share_log

4D Molecular Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(7.88%),Deep Track Biotechnology Master Fund, Ltd.(7.88%), etc.

4D Molecular Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(7.88%),Deep Track Biotechnology Master Fund, Ltd.(7.88%)等

美股SEC公告 ·  2024/11/14 22:17
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息